These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25535041)
1. Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV. Wu ES; Rothbard A; Holtgrave DR; Blank MB Community Ment Health J; 2016 May; 52(4):439-45. PubMed ID: 25535041 [TBL] [Abstract][Full Text] [Related]
2. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV. Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024 [TBL] [Abstract][Full Text] [Related]
3. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART). Rothbard AB; Lee S; Blank MB J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006 [TBL] [Abstract][Full Text] [Related]
4. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS. Rothbard AB; Metraux S; Blank MB Psychiatr Serv; 2003 Sep; 54(9):1240-6. PubMed ID: 12954940 [TBL] [Abstract][Full Text] [Related]
5. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Blank MB; Hanrahan NP; Fishbein M; Wu ES; Tennille JA; Ten Have TR; Kutney-Lee AM; Gross R; Hines JM; Coyne JC; Aiken LH Psychiatr Serv; 2011 Nov; 62(11):1318-24. PubMed ID: 22211211 [TBL] [Abstract][Full Text] [Related]
6. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882 [TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence. Ownby RL; Waldrop-Valverde D; Jacobs RJ; Acevedo A; Caballero J BMC Med Inform Decis Mak; 2013 Feb; 13():29. PubMed ID: 23446180 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. Palmer NB; Salcedo J; Miller AL; Winiarski M; Arno P AIDS Patient Care STDS; 2003 Dec; 17(12):635-44. PubMed ID: 14746657 [TBL] [Abstract][Full Text] [Related]
9. Adherence to HIV antiretrovirals among persons with serious mental illness. Wagner GJ; Kanouse DE; Koegel P; Sullivan G AIDS Patient Care STDS; 2003 Apr; 17(4):179-86. PubMed ID: 12737641 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. Brogan AJ; Talbird SE; Cohen C Value Health; 2011; 14(5):657-64. PubMed ID: 21839403 [TBL] [Abstract][Full Text] [Related]
11. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. Ma A; Chen DM; Chau FM; Saberi P AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958 [TBL] [Abstract][Full Text] [Related]
12. 'I was thinking too much': experiences of HIV-positive adults with common mental disorders and poor adherence to antiretroviral therapy in Zimbabwe. Kidia K; Machando D; Bere T; Macpherson K; Nyamayaro P; Potter L; Makadzange T; Munjoma R; Marufu M; Araya R; Safren S; O'Cleirigh C; Chibanda D; Abas M Trop Med Int Health; 2015 Jul; 20(7):903-13. PubMed ID: 25754063 [TBL] [Abstract][Full Text] [Related]
13. The connection between serious life events, anti-retroviral adherence, and mental health among HIV-positive individuals in the Western Cape, South Africa. Brinkley-Rubinstein L; Chadwick C; Graci M AIDS Care; 2013; 25(12):1581-5. PubMed ID: 23656514 [TBL] [Abstract][Full Text] [Related]
14. Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South India. Batavia AS; Balaji K; Houle E; Parisaboina S; Ganesh AK; Mayer KH; Solomon S AIDS Behav; 2010 Aug; 14(4):794-8. PubMed ID: 20052529 [TBL] [Abstract][Full Text] [Related]
15. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Biddle AK; Simpson KN Value Health; 2000; 3(3):186-201. PubMed ID: 16464183 [TBL] [Abstract][Full Text] [Related]
16. Does Diagnosis Make a Difference? Estimating the Impact of an HIV Medication Adherence Intervention for Persons with Serious Mental Illness. Dalseth N; Reed RS; Hennessy M; Eisenberg MM; Blank MB AIDS Behav; 2018 Jan; 22(1):265-275. PubMed ID: 28536741 [TBL] [Abstract][Full Text] [Related]
17. "Payment by Results"--financial incentives and motivational interviewing, adherence interventions in young adults with perinatally acquired HIV-1 infection: a pilot program. Foster C; McDonald S; Frize G; Ayers S; Fidler S AIDS Patient Care STDS; 2014 Jan; 28(1):28-32. PubMed ID: 24428797 [TBL] [Abstract][Full Text] [Related]
18. Increasing quality of life and reducing HIV burden: the PATH+ intervention. Blank MB; Hennessy M; Eisenberg MM AIDS Behav; 2014 Apr; 18(4):716-25. PubMed ID: 24000053 [TBL] [Abstract][Full Text] [Related]
19. Healthcare costs associated with antiretroviral adherence among medicaid patients. Pruitt Z; Robst J; Langland-Orban B; Brooks RG Appl Health Econ Health Policy; 2015 Feb; 13(1):69-80. PubMed ID: 25403718 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of antiretroviral treatment in patients from Pereira and Manizales. Machado-Alba JE; González-Santos DM; Vidal-Guitart X Rev Salud Publica (Bogota); 2011 Jun; 13(3):492-503. PubMed ID: 22031001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]